SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Biotech companies at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

17 biotech companies are at SNO 2026 — 22 presentations on the program. Most represented: Edison Oncology (3 on the program), HDT Bio (2 on the program), SpringWorks Therapeutics (1 on the program). 1 of them have their own page in this guide. As of Nov 12, 2026.

All 419 organizations at SNO 2026 →

Topic
Top represented
Showing 1–17 of 17 organizations
OrganizationSNO 2026 Attendance
Edison Oncology
Menlo Park, CA
Biotech
A clinical-stage biopharmaceutical company developing biomarker-driven cancer therapies, including brain-penetrant candidates for brain tumors.
Poster
Fri Nov 13
7:30–9:30pm
Poster
Fri Nov 13
7:30–9:30pm
HDT Bio
Seattle, WA
Biotech
A clinical-stage biotechnology company developing immune-based treatments for cancer and infectious diseases, including glioblastoma approaches.
Poster
Fri Nov 13
7:30–9:30pm
Talk
Sat Nov 14
10:22–10:29am
◆Platinum Supporter
BiotechPlatinum Supporter
A biotechnology company developing targeted medicines for rare tumors and other serious diseases.
Talk
Thu Nov 12
6–7:15pm
Latest Data, Longer View: Treating NF1-Associated Symptomatic PN Across the Patient Journey
Liberty Salon A+B - Philadelphia Marriott Downtown
Rare tumors
Talk
Fri Nov 13
12:21–12:24pm
The impact of mirdametinib on pain medication use in adult patients from a United States (US) claims dataset
Exhibit Hall D & E, Second Floor, Convention Center · Abstract QLTI-05
Health equity
CJ
Chengdu Jinrui Foundation Biotech
Chengdu, China
Biotech
A biotechnology company developing liposomal honokiol, an investigational treatment studied for recurrent glioblastoma.
Biotech
A drug-discovery company using computational methods to develop precision-medicine therapies for neurological and brain diseases.
Talk
Sat Nov 14
11:51–11:54am
Functional genomics nominates cytarabine as a biomarker-guided therapy for leptomeningeal glioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EPCO-12
Pathology
FYR Bio
Missoula, MT
Biotech
A biotechnology company developing extracellular-vesicle-based liquid biopsy and diagnostic technologies, including tools relevant to brain tumor monitoring.
Poster
Fri Nov 13
7:30–9:30pm
Development of a multiomic, mutation-informed blood plasma extracellular vesicle workflow for IDH1 mutant glioma monitoring
Exhibit Hall D & E, Second Floor, Convention Center · Abstract BIOM-50
Biomarkers
Hemispherian
Oslo, Norway
Biotech
A clinical-stage biotechnology company developing small-molecule cancer therapies, including GLIX1 for glioblastoma.
Poster
Fri Nov 13
7:30–9:30pm
IN8bio
New York, NY
Biotech
A biotechnology company developing gamma-delta T-cell therapies for cancer, including glioblastoma.
Precision NeuroMed
Redwood City, CA
Biotech
A clinical-stage biotechnology company developing precision-delivery therapies for glioblastoma and other neurological diseases.
Poster
Fri Nov 13
7:30–9:30pm
RadioMedix
Houston, TX
Biotech
A radiopharmaceutical company developing targeted agents for cancer diagnosis, imaging, and radionuclide therapy.
Poster
Fri Nov 13
7:30–9:30pm
Crossing the blood–brain barrier with LDLR-targeted Pb203/Pb212 radiotheranostics for glioblastoma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract EXTH-66
Therapeutics
UP Oncolytics
Milwaukee, WI
Biotech
A biotechnology company developing viral therapies for cancers including glioblastoma.
Poster
Fri Nov 13
7:30–9:30pm
Biotech
A biopharmaceutical company developing targeted therapies for people with cancer, including pediatric cancers.
Talk
Fri Nov 13
6–7:15pm
Tovorafenib 3-Year Update
114, Michel A Nutter Theatre, First Floor, Convention Center
Pediatrics · Therapeutics
Cerenome
Houston, TX
◇Contributing Supporter
BiotechContributing Supporter
A CNS oncology company combining diagnostics and targeted therapeutics for central nervous system cancers.
Talk
Sat Nov 14
7–8:15am
Fore Biotherapeutics
Philadelphia, PA
◇Contributing Supporter
BiotechContributing Supporter
A biotechnology company developing targeted cancer therapies, including treatments for tumors with BRAF alterations.
Talk
Thu Nov 12
6–7:15pm
Nuvation Bio
New York, NY
◇Contributing Supporter
BiotechContributing Supporter
A biopharmaceutical company developing targeted therapies, including treatments for brain and other cancers.
Talk
Thu Nov 12
6–7:15pm
Telix Pharmaceuticals
Melbourne, Australia
◆Platinum Supporter
BiotechPlatinum Supporter
A radiopharmaceutical company developing molecular imaging and therapeutic products, including programs relevant to oncology.
Talk
Fri Nov 13
6–7:15pm
Two Decades of Experience, a New Era in the U.S.: Integrating FET PET into Glioma Care
Liberty Ballroom, Level 3, Philadelphia Marriott Downtown
Neuroimaging
◇Contributing Supporter
BiotechContributing Supporter
A biotechnology company developing personalized immunotherapies for cancer, including glioblastoma.
Sponsor
In the meeting’s sponsor directory, with no session on the public program

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from biotech companies

Tell us what you sell and we’ll find the people at these biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SNO 2026 by

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction